Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 3, 2025

Data from Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma

View Full Paper
Ask AI
Bookmark
Share

Authors

NBNicole BricenoJJJinkyu JungALAmin Li

Discussion

Loading...

Member takes

Overview

Analysis reveals methylation patterns of MGMT influence chemotherapy sensitivity in glioma, suggesting clinical implications.

Key Points

  • Methylation patterns of mgmt significantly modulate response to carmustine in glioma cell lines.
  • Analysis of 36 glioma cell lines indicates that mgmt body methylation negatively correlates with carmustine sensitivity.
  • Utilizing data from The Cancer Genome Atlas highlights the importance of integrating body and promoter methylation for therapeutic predictions.
  • Results show that mgmt mRNA expression is positively correlated with body methylation and negatively correlated with promoter methylation.

Cite This Study

Briceno et al. (2025) studied this question.

synapsesocial.com/papers/68e034f7f0e39f13e7fa3076https://doi.org/10.1158/1535-7163.c.8065156
View Full Paper
Ask AI
Bookmark
Share